vs
Side-by-side financial comparison of FIRST HORIZON CORP (FHN) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
FIRST HORIZON CORP is the larger business by last-quarter revenue ($888.0M vs $617.8M, roughly 1.4× Hims & Hers Health, Inc.). FIRST HORIZON CORP runs the higher net margin — 29.4% vs 3.3%, a 26.1% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 21.8%). FIRST HORIZON CORP produced more free cash flow last quarter ($389.0M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 20.0%).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
FHN vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $888.0M | $617.8M |
| Net Profit | $261.0M | $20.6M |
| Gross Margin | — | 71.9% |
| Operating Margin | 38.5% | 1.5% |
| Net Margin | 29.4% | 3.3% |
| Revenue YoY | 21.8% | 28.4% |
| Net Profit YoY | 57.2% | -20.8% |
| EPS (diluted) | $0.51 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $888.0M | $617.8M | ||
| Q3 25 | $889.0M | $599.0M | ||
| Q2 25 | $830.0M | $544.8M | ||
| Q1 25 | $812.0M | $586.0M | ||
| Q4 24 | $729.0M | $481.1M | ||
| Q3 24 | $827.0M | $401.6M | ||
| Q2 24 | — | $315.6M | ||
| Q1 24 | $819.0M | $278.2M |
| Q4 25 | $261.0M | $20.6M | ||
| Q3 25 | $262.0M | $15.8M | ||
| Q2 25 | $241.0M | $42.5M | ||
| Q1 25 | $218.0M | $49.5M | ||
| Q4 24 | $166.0M | $26.0M | ||
| Q3 24 | $218.0M | $75.6M | ||
| Q2 24 | — | $13.3M | ||
| Q1 24 | $192.0M | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | 38.5% | 1.5% | ||
| Q3 25 | 38.7% | 2.0% | ||
| Q2 25 | 37.2% | 4.9% | ||
| Q1 25 | 35.1% | 9.9% | ||
| Q4 24 | 28.8% | 3.9% | ||
| Q3 24 | 34.0% | 5.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | 31.0% | 3.6% |
| Q4 25 | 29.4% | 3.3% | ||
| Q3 25 | 29.5% | 2.6% | ||
| Q2 25 | 29.0% | 7.8% | ||
| Q1 25 | 26.8% | 8.4% | ||
| Q4 24 | 22.8% | 5.4% | ||
| Q3 24 | 26.4% | 18.8% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | 23.4% | 4.0% |
| Q4 25 | $0.51 | $0.08 | ||
| Q3 25 | $0.50 | $0.06 | ||
| Q2 25 | $0.45 | $0.17 | ||
| Q1 25 | $0.41 | $0.20 | ||
| Q4 24 | $0.29 | $0.10 | ||
| Q3 24 | $0.40 | $0.32 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | $0.33 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.8B | $540.9M |
| Total Assets | $83.9B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $8.8B | $540.9M | ||
| Q3 25 | $8.9B | $581.0M | ||
| Q2 25 | $9.0B | $562.7M | ||
| Q1 25 | $8.7B | $549.3M | ||
| Q4 24 | $8.8B | $476.7M | ||
| Q3 24 | $9.0B | $440.1M | ||
| Q2 24 | — | $362.0M | ||
| Q1 24 | $8.9B | $344.5M |
| Q4 25 | $83.9B | $2.2B | ||
| Q3 25 | $83.2B | $2.2B | ||
| Q2 25 | $82.1B | $1.9B | ||
| Q1 25 | $81.5B | $891.7M | ||
| Q4 24 | $82.2B | $707.5M | ||
| Q3 24 | $82.6B | $602.3M | ||
| Q2 24 | — | $480.5M | ||
| Q1 24 | $81.8B | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $396.0M | $61.3M |
| Free Cash FlowOCF − Capex | $389.0M | $-2.5M |
| FCF MarginFCF / Revenue | 43.8% | -0.4% |
| Capex IntensityCapex / Revenue | 0.8% | 10.3% |
| Cash ConversionOCF / Net Profit | 1.52× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $595.0M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $396.0M | $61.3M | ||
| Q3 25 | $-200.0M | $148.7M | ||
| Q2 25 | $83.0M | $-19.1M | ||
| Q1 25 | $349.0M | $109.1M | ||
| Q4 24 | $191.0M | $86.4M | ||
| Q3 24 | $389.0M | $85.3M | ||
| Q2 24 | — | $53.6M | ||
| Q1 24 | $838.0M | $25.8M |
| Q4 25 | $389.0M | $-2.5M | ||
| Q3 25 | $-208.0M | $79.3M | ||
| Q2 25 | $74.0M | $-69.5M | ||
| Q1 25 | $340.0M | $50.1M | ||
| Q4 24 | $174.0M | $59.5M | ||
| Q3 24 | $383.0M | $79.4M | ||
| Q2 24 | — | $47.6M | ||
| Q1 24 | $828.0M | $11.8M |
| Q4 25 | 43.8% | -0.4% | ||
| Q3 25 | -23.4% | 13.2% | ||
| Q2 25 | 8.9% | -12.8% | ||
| Q1 25 | 41.9% | 8.5% | ||
| Q4 24 | 23.9% | 12.4% | ||
| Q3 24 | 46.3% | 19.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | 101.1% | 4.3% |
| Q4 25 | 0.8% | 10.3% | ||
| Q3 25 | 0.9% | 11.6% | ||
| Q2 25 | 1.1% | 9.3% | ||
| Q1 25 | 1.1% | 10.1% | ||
| Q4 24 | 2.3% | 5.6% | ||
| Q3 24 | 0.7% | 1.5% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | 1.2% | 5.0% |
| Q4 25 | 1.52× | 2.98× | ||
| Q3 25 | -0.76× | 9.43× | ||
| Q2 25 | 0.34× | -0.45× | ||
| Q1 25 | 1.60× | 2.20× | ||
| Q4 24 | 1.15× | 3.32× | ||
| Q3 24 | 1.78× | 1.13× | ||
| Q2 24 | — | 4.03× | ||
| Q1 24 | 4.36× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHN
| Commercial Consumer And Wealth Segment | $776.0M | 87% |
| Other | $88.0M | 10% |
| Corporate | $24.0M | 3% |
HIMS
Segment breakdown not available.
